Reduce your R&D/research costs:
Locate in Alsace and benefit from Europe's
best R&D tax credits!
In France, you can benefit from the most advantageous R&D tax credit in all of Europe. You can reduce your research costs by 30% the first year.
Double R&D tax credit return if you outsource to a public research laboratory, Up to 60% public funding for public-private R&D partnerships!
Click here for more information
Alsace BioValley Cluster partners with Massachusetts companies to apply for joint life sciences R&D funding!
The MLSC partners with our Alsace region to award funding to support winning projects demonstrating innovative and collaborative research and development (R&D) in Massachusetts and in the partnering region. The program will enable company partners from biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics to submit project applications.
The high-level specialized skills of Alsatian Life Sciences / Health companies, combined with the expertise of Alsace BioValley Cluster in international partnerships, made the difference.
Read the international MLSC press release
Contact : international@alsace-biovalley.com
Make your European expansion easier!
Alsace's is your gateway to a unique tri-national Health-Pharma Network
Located in Europe's golden triangle for research, Alsace is situated at the heart of the BioValley, a tri-national network uniting French, German and Swiss players in the health and life sciences. More than 40% of pharmaceutical leaders are already established here and benefit from the region's exceptional advantages like strategic location and one of the highest concentrations of research labs in Europe.
Click here to discover Alsace's advantages
Reduce your R&D/research costs:
Locate in Alsace and benefit from Europe's
best R&D tax credits!
In France, you can benefit from the most advantageous R&D tax credit in all of Europe. You can reduce your research costs by 30% the first year.
Double R&D tax credit return if you outsource to a public research laboratory, Up to 60% public funding for public-private R&D partnerships!
Click here for more information
E-newsletter
